Netherlands Healthcare, Regulatory and Reimbursement Landscape - CountryFocus

Netherlands Healthcare, Regulatory and Reimbursement Landscape - CountryFocus

  • October 2020 •
  • 135 pages •
  • Report ID: 5981805 •
  • Format: PDF
Netherlands Healthcare, Regulatory and Reimbursement Landscape - CountryFocus

Summary
The analyst has released its latest report: “Netherlands Healthcare, Regulatory and Reimbursement Landscape - CountryFocus”.The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in the Netherlands.

It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure.Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.

It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by team of industry experts.

The Netherlands pharmaceutical market grew from €4.61B in 2012 to €4.64B in 2018 at a Compound Annual Growth Rate (CAGR) of 0.12%. However, in terms of USD, the pharmaceutical market decreased from $5.92B in 2012 to $5.48B in 2018, at a negative CAGR of 1.27%. This difference is due to currency exchange fluctuations. The pharmaceutical market is expected to reach $5.01B in 2025. The Netherlands’ robust healthcare system and growing investment in R&D are driving the pharmaceutical market. However, reimbursement policies favoring the usage of generics is restricting pharmaceutical market growth.

Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the Netherlands, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Novartis, GSK, Sanofi, Pfizer, and AstraZeneca
- Profiles and SWOT analyses of the major players in the medical device market: Abbott, GE Healthcare, Fresenius, Roche Diagnostics, and Alcon
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in The Netherlands healthcare market

Reasons to Buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Netherlands’ healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Netherlands’ healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
Loading...

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.